Azimi et al. reported the TRPC1 expression levels in a data set from the University of North Carolina of 855 breast cancer patients, classified and reported based on the 50-signature genes subtype classification known as PAM50 [42,82]. This evidence concerns the gene TRPC1 and breast carcinoma.